Dr. Daniel Yamshon, DO Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 7100 Carpenter Rd, Family Health Center, Skokie, IL 60077 Phone: 847-546-5800 Fax: 847-328-8482 |
News Archive
New guidelines released by the Canadian Heart and Stroke Foundation reveal the health of millions of Canadians is being placed at risk because of avoidable delays in diagnosis and treatment of high blood pressure (hypertension).
Scientists at the National Cancer Institute have generated a data set of cancer-specific genetic variations and are making these data available to the research community, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Weight gain in early pregnancy has the greatest impact on infant size at birth, according to a new study published today in Obesity. The study is the largest ever analysis of the effect that weight gain in early pregnancy has on infant size.
B-Bridge International proudly unveils the first brainwave athletic trainer. Powered by NeuroSky, the leader in mass-market Brain-Computer Interface technology, the BrainAthlete system is the first sports training unit available for general consumers to track an athlete's level of concentration, helping them find their "zone." Engineered into a standard golf visor, three non-invasive contact points in the headband monitor the EEG electrical activity from the brain to determine the athlete's mental states.
Optimer Pharmaceuticals, Inc. announced the presentation of new data from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection. The data, presented by Stuart Johnson, M.D. during an oral session at the annual meeting of Digestive Disease Week in New Orleans, indicated that treatment with fidaxomicin significantly improved the recurrence rate and global cure rate in CDI patients requiring concomitant antibiotics, compared to vancomycin.
› Verified 2 days ago